Prognostic Value of Pretreatment Systemic Inflammatory Markers for cSCC

Supplemental Figures
Mendeley Supplemental Figure 1. Receiver operating characteristic (ROC) curves for determining the optimal cut-off values of preoperative systemic inflammatory markers for recurrence: (A) Neutrophil-to-Lymphocyte Ratio (NLR) (AUC = 0.696); (B) Lymphocyte-to-Monocyte Ratio (LMR) (AUC = 0.612); (C) Platelet-to-Lymphocyte Ratio (PLR) (AUC = 0.610); (D) Red Cell Distribution Width (RDW) (AUC = 0.495)

Mendeley Supplemental Figure 2. Kaplan-Meier survival analysis for distant metastasis-free survival based on preoperative systemic inflammatory markers: (A) Neutrophil-to-Lymphocyte Ratio (NLR) (P < 0.001); (B) Lymphocyte-to-Monocyte Ratio (LMR) (P < 0.001); (C) Platelet-to-Lymphocyte Ratio (PLR) (P = 0.001); (D) Red Cell Distribution Width (RDW) (P < 0.001).

Mendeley Supplemental Figure 3. Kaplan-Meier survival analysis for disease-specific survival based on preoperative systemic inflammatory markers: (A) Neutrophil-to-Lymphocyte Ratio (NLR) (P < 0.001); (B) Lymphocyte-to-Monocyte Ratio (LMR) (P < 0.001); (C) Platelet-to-Lymphocyte Ratio (PLR) (P < 0.001); (D) Red Cell Distribution Width (RDW) (P < 0.001).

Mendeley Supplemental Figure 4. Kaplan-Meier survival analysis for overall survival based on preoperative systemic inflammatory markers: (A) Neutrophil-to-Lymphocyte Ratio (NLR) (P < 0.001); (B) Lymphocyte-to-Monocyte Ratio (LMR) (P = 0.002); (C) Platelet-to-Lymphocyte Ratio (PLR) (P = 0.003); (D) Red Cell Distribution Width (RDW) (P < 0.001).

Supplemental Tables
Mendeley Supplementary Table I. Inflammatory markers, calculated ratios, and cut-off values
Mendeley Supplementary Table II. Cox univariate and multivariate analyses for distant metastasis-free survival
Mendeley Supplementary Table III. Cox univariate and multivariate analyses for disease-specific survival
Mendeley Supplementary Table IV. Cox univariate and multivariate analyses for overall survival